Glycyrrhizin in Licorice Root Neutralizes SARS-CoV-2

A pre-print paper revealed that glycyrrhizin in licorice root neutralizes SARS-CoV-2 in vitro by inhibiting the main protease Mpro. An in-silico simulation study suggested the antiviral activity of glycyrrhizin against SARS-CoV-2. Researchers from Germany analyzed aqueous licorice root extract. Cytotoxicity was determined at 4-time points using Orangu cell counting solution.

The licorice root extract exhibited neutralizing effects even at a subtoxic concentration of 2 mg/ml, which is lower than the typical consuming dilution. For example, in tea, it is 12.5 mg/ml. Complete neutralization of the virus was achieved at 0.5 mg/ml under pre- and 1 mg/ml under post-entry conditions. Researchers found only a tiny difference in the antiviral activity of glycyrrhizin between pre-and post-entry conditions. So they concluded that glycyrrhizin neutralizes the virus by a mechanism that is different from inhibition of TMPRSS2.

In further experiments, the researchers found that glycyrrhizin fully inhibited Mpro activity at a concentration of 2000 µM (1.6 mg/ml) and reduced Mpro activity by 70.3% at a concentration of 30 µM (0.024 mg/ml). Mpro is responsible for the processing of viral polyproteins translated from the viral RNA and hence essential for virus replication. Thus, they concluded that glycyrrhizin effectively neutralizes SARS-CoV-2 by inhibiting the viral main protease Mpro. This study highlights that glycyrrhizin is a promising antiviral compound and further investigations could lead to it being a treatment in COVID-19.

To know more about origin, virology of COVID-19, Click here

To know more about emerging themes in COVID-19, Click here

To know more about how WhiteCoats can help you in your professional advancement, visit www.whitecoats.com

Want to set up an online consultation for your practice, Click here

Ref link: https://www.biorxiv.org/content/10.1101/2020.12.18.423104v1

#Featured